West Pharmaceutical Servi... (WST)
NYSE: WST
· Real-Time Price · USD
245.92
-0.28 (-0.11%)
At close: Aug 15, 2025, 3:59 PM
246.20
0.11%
After-hours: Aug 15, 2025, 05:52 PM EDT
West Pharmaceutical Services Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 509.7M | 404.2M | 484.6M | 490.9M | 446.2M | 601.8M | 853.9M | 898.6M | 796.3M | 886.3M | 894.3M | 729M | 718.5M | 667.7M | 762.6M | 688M | 576.2M | 483.7M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 224.7M | 211.9M | 202.1M | 217.5M | 198.2M | 202.5M | 210M | 195.4M | 202.8M | 208.8M | 204.9M | 188.6M | 193.3M | 208.1M | 207.7M | 215.7M | 211.7M | 211.9M |
Other Long-Term Assets | 70.5M | 70.2M | 74.3M | 69.3M | 50.1M | 19M | 21.3M | 38.8M | 40.3M | 36.7M | 38.4M | 53.9M | 67M | 57.6M | 55.9M | 48.6M | 42.3M | 39.4M |
Receivables | 582.4M | 543.6M | 552.5M | 524.3M | 479.4M | 524M | 512M | 519.1M | 534.4M | 513.4M | 507.4M | 485.3M | 528.4M | 498.7M | 489M | 476.4M | 480.5M | 465.7M |
Inventory | 421.1M | 388.7M | 377M | 401.2M | 419.2M | 429.9M | 434.7M | 431.8M | 449.4M | 447M | 414.8M | 413.1M | 411.6M | 416.5M | 378.4M | 353.8M | 345.2M | 310.2M |
Other Current Assets | 167.7M | 121M | 124M | 134.2M | 138.2M | 137.2M | 135.8M | 122.8M | 94.1M | 90.5M | 103M | 106.2M | 112.6M | 107.6M | 112M | 80.1M | 75.1M | 67.4M |
Total Current Assets | 1.68B | 1.46B | 1.54B | 1.55B | 1.48B | 1.69B | 1.94B | 1.97B | 1.87B | 1.94B | 1.92B | 1.73B | 1.77B | 1.69B | 1.74B | 1.6B | 1.48B | 1.33B |
Property-Plant & Equipment | 1.83B | 1.74B | 1.69B | 1.68B | 1.6B | 1.55B | 1.51B | 1.41B | 1.36B | 1.32B | 1.26B | 1.16B | 1.15B | 1.14B | 1.13B | 1.06B | 1.04B | 995.3M |
Goodwill & Intangibles | 120.6M | 117.5M | 116.9M | 121.1M | 120.2M | 121.5M | 123.6M | 122.5M | 124.8M | 125.6M | 125.7M | 122.1M | 126.6M | 130.6M | 132.9M | 135M | 137.8M | 138.2M |
Total Long-Term Assets | 2.27B | 2.16B | 2.11B | 2.12B | 2.01B | 1.91B | 1.89B | 1.78B | 1.8B | 1.79B | 1.7B | 1.58B | 1.59B | 1.6B | 1.57B | 1.54B | 1.46B | 1.41B |
Total Assets | 3.95B | 3.62B | 3.64B | 3.68B | 3.49B | 3.6B | 3.83B | 3.75B | 3.67B | 3.72B | 3.62B | 3.32B | 3.36B | 3.29B | 3.31B | 3.14B | 2.93B | 2.74B |
Account Payables | 239M | 228.4M | 239.3M | 224.3M | 211.7M | 240.1M | 242.4M | 219.8M | 218M | 233.8M | 215.4M | 188.9M | 220M | 248.2M | 232.2M | 207.7M | 205.1M | 204.3M |
Deferred Revenue | n/a | n/a | 49.6M | n/a | n/a | n/a | 41.7M | n/a | n/a | n/a | 57.3M | n/a | n/a | n/a | 48.7M | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | 132.9M | 133.4M | 134M | 55.2M | 2.2M | 2.2M | 2.2M | 2.2M | 44.2M | 44.2M | 44.2M | 44.2M | 2.3M | 2.3M |
Other Current Liabilities | 222.8M | 186.4M | 71.6M | 159.3M | 169M | 173.6M | 54.2M | 136.5M | 163.1M | 158M | 54M | 155.7M | 179.1M | 170.4M | 45.1M | 145.1M | 150.5M | 147.2M |
Total Current Liabilities | 604.6M | 526.7M | 550.4M | 516.5M | 633.7M | 648.4M | 671.8M | 533.5M | 511.6M | 534.9M | 519M | 456.7M | 565.1M | 584.8M | 594.1M | 558.6M | 472.6M | 482.8M |
Long-Term Debt | 202.6M | 202.6M | 202.6M | 202.6M | 72.9M | 72.8M | 72.8M | 152.1M | 205.6M | 206.1M | 206.7M | 207.2M | 207.8M | 208.3M | 208.8M | 209.9M | 251.8M | 252.3M |
Other Long-Term Liabilities | 113.7M | 105.7M | 105.8M | 112.2M | 107.7M | 105.4M | 106.7M | 101.4M | 103M | 102M | 98.9M | 88.3M | 93M | 103.2M | 107.6M | 106.8M | 108.3M | 106M |
Total Long-Term Liabilities | 419.1M | 408.4M | 410.7M | 406.5M | 278.9M | 273.3M | 276.7M | 353M | 411.3M | 412.5M | 412.9M | 389.3M | 372.2M | 383.7M | 384.3M | 381.7M | 428.3M | 427.9M |
Total Liabilities | 1.02B | 935.1M | 961.1M | 923M | 912.6M | 921.7M | 948.5M | 886.5M | 922.9M | 947.4M | 931.9M | 846M | 937.3M | 968.5M | 978.4M | 940.3M | 900.9M | 910.7M |
Total Debt | 303.3M | 303.2M | 302.3M | 304.8M | 310.7M | 306.6M | 309M | 306.8M | 311.3M | 314.4M | 317.9M | 299.9M | 332.5M | 331.2M | 325.3M | 315.6M | 319.4M | 321.4M |
Common Stock | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M | 18.8M |
Retained Earnings | 4.14B | 4.03B | 3.96B | 3.86B | 3.72B | 3.62B | 3.52B | 3.42B | 3.25B | 3.11B | 2.99B | 2.91B | 2.79B | 2.62B | 2.46B | 2.34B | 2.16B | 1.99B |
Comprehensive Income | -88.7M | -205.5M | -258.1M | -136.3M | -216.9M | -192.3M | -143.8M | -223M | -183.5M | -168.4M | -183M | -308.5M | -245.9M | -182.4M | -159.6M | -155.7M | -133.2M | -140.2M |
Shareholders Equity | 2.93B | 2.68B | 2.68B | 2.75B | 2.58B | 2.68B | 2.88B | 2.87B | 2.75B | 2.78B | 2.68B | 2.47B | 2.42B | 2.33B | 2.34B | 2.2B | 2.03B | 1.83B |
Total Investments | 224.7M | 211.9M | 202.1M | 217.5M | 198.2M | 202.5M | 210M | 195.4M | 202.8M | 208.8M | 204.9M | 188.6M | 193.3M | 208.1M | 207.7M | 215.7M | 211.7M | 211.9M |